Tacrolimus, an immunosuppressant, is used to reduce organ rejection in transplant patients by suppressing the immune system. This approval broadens Biocon’s portfolio of complicated medicinal ...
and patients only on CNI (cyclosporine or tacrolimus) and glucocorticoids. All patients had an available kidney biopsy within a year of enrollment. The study was registered in the ClinicalTrials.gov ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback